scholarly journals RFLP analysis of Duchenne muscular dystrophy gene in population of Leningrad and in high risk families

1990 ◽  
Vol 6 (2) ◽  
pp. 52-55 ◽  
Author(s):  
V. N. Gorbunova ◽  
V. V. Krasilnikov ◽  
M. V. Aseev ◽  
N. V. Santzevich ◽  
V. S. Buranov
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
High Risk ◽  
Muscular Dystrophy ◽  
Rflp Analysis ◽  
Duchenne Muscular Dystrophy Gene ◽  
High Risk Families

The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle

Nature ◽  
1988 ◽  
Vol 333 (6172) ◽  
pp. 466-469 ◽  
Author(s):  
Elizabeth E. Zubrzycka-Gaarn ◽  
Dennis E. Bulman ◽  
George Karpati ◽  
Arthur H. M. Burghes ◽  
Bonnie Belfall ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Gene Product ◽  
Human Skeletal Muscle ◽  
Duchenne Muscular Dystrophy Gene

scholarly journals Ultrastructural Localisation Of Ricinus Communis-I Lectin To Skeletal Muscle From Foetuses At High Risk For Duchenne Muscular Dystrophy

1987 ◽  
Vol 22 (2) ◽  
pp. 222-222
Author(s):  
T Voit ◽  
C A Sewry ◽  
M J Dunn ◽  
V Dubowitz
Keyword(s):  
Skeletal Muscle ◽  
Duchenne Muscular Dystrophy ◽  
High Risk ◽  
Muscular Dystrophy ◽  
Ricinus Communis

scholarly journals Consensus Statement on the Management of Duchenne Muscular Dystrophy in Saudi Arabia During the Coronavirus Disease 2019 Pandemic

2021 ◽  
Vol 9 ◽  
Author(s):  
Ahmed K. Bamaga ◽  
Fouad Alghamdi ◽  
Nahla Alshaikh ◽  
Waleed Altwaijri ◽  
Fahad A. Bashiri ◽  
...  
Keyword(s):  
Health Care ◽  
Saudi Arabia ◽  
Duchenne Muscular Dystrophy ◽  
High Risk ◽  
Muscular Dystrophy ◽  
Angiotensin Receptor Blockers ◽  
Treatment Protocol ◽  
Gene Correction ◽  
Respiratory Complications ◽  
New Gene

Background: The coronavirus disease 2019 (COVID-19) pandemic has caused overwhelming challenges in healthcare worldwide. During such an outbreak, some needs of high-risk groups who require regular follow-ups and long-term management are not met. The vulnerable populations include patients with Duchenne muscular dystrophy (DMD). Duchenne muscular dystrophy is characterized by respiratory complications caused by muscle weakness. Hence, patients with this condition are at high risk of severe diseases including COVID-19.Methods: To standardize care and provide optimal treatment to DMD patients in Saudi Arabia during the COVID-19 pandemic, a panel of experts including neurologists and pediatricians consolidated recommendations for healthcare professionals and caregivers.Results: During this pandemic, substituting unnecessary clinic visits with virtual clinic services was highly recommended, if possible, without compromising clinical outcomes. Duchenne muscular dystrophy patients with respiratory complications should be closely monitored, and those with cardiovascular complications must continue taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Moreover, individualized home-based rehabilitation management was preferred. Glucocorticoid and new gene correction therapies should be continued. However, new gene correction therapy must be post-poned in newly diagnosed patients. A multidisciplinary decision was required before the initiation of hydroxychloroquine based on the COVID-19 treatment protocol.Conclusion: COVID-19 has caused challenges and transformed access to health care. However, these limitations have provided opportunities for the health care system to adapt. Further, telemedicine has become a reliable platform for follow-up appointments that should be conducted by a multidisciplinary team including physicians, dieticians, and physical therapists.

Codon Optimization of the Microdystrophin Gene for Duchenne Muscular Dystrophy Gene Therapy

2010 ◽  
pp. 21-37 ◽  
Author(s):  
Takis Athanasopoulos ◽  
Helen Foster ◽  
Keith Foster ◽  
George Dickson
Keyword(s):  
Gene Therapy ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Codon Optimization ◽  
Duchenne Muscular Dystrophy Gene

Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene

Genomics ◽  
1990 ◽  
Vol 7 (4) ◽  
pp. 602-606 ◽  
Author(s):  
Stephen Abbs ◽  
Roland G. Roberts ◽  
Christopher G. Mathew ◽  
David R. Bentley ◽  
Martin Bobrow
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Recombination Frequency ◽  
Intragenic Recombination ◽  
Accurate Assessment ◽  
Duchenne Muscular Dystrophy Gene

Molecular cloning and protein expression of Duchenne muscular dystrophy gene products in porcine retina

2005 ◽  
Vol 15 (7) ◽  
pp. 476-487 ◽  
Author(s):  
Agnès Bordais ◽  
Francisco Bolaños-Jimenez ◽  
Patrice Fort ◽  
Carolina Varela ◽  
José-Alain Sahel ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Protein Expression ◽  
Molecular Cloning ◽  
Gene Products ◽  
Duchenne Muscular Dystrophy Gene
Sign in / Sign up

Export Citation Format

Share Document